These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29503200)

  • 1. Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.
    Iyer PS; Mavoungou LO; Ronzoni F; Zemla J; Schmid-Siegert E; Antonini S; Neff LA; Dorchies OM; Jaconi M; Lekka M; Messina G; Mermod N
    Mol Ther; 2018 Apr; 26(4):1093-1108. PubMed ID: 29503200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts.
    Meng J; Sweeney NP; Doreste B; Muntoni F; McClure M; Morgan J
    Hum Gene Ther; 2020 Feb; 31(3-4):241-252. PubMed ID: 31801386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
    Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
    Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mesoangioblast cell fate and improved promyogenic potential of a satellite cell-like subpopulation upon transplantation in dystrophic murine muscles.
    Mavoungou LO; Neuenschwander S; Pham U; Iyer PS; Mermod N
    Stem Cell Res; 2019 Dec; 41():101619. PubMed ID: 31683098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell transplantation-mediated dystrophin supplementation efficacy in Duchenne muscular dystrophy mouse motor function improvement demonstrated by enhanced skeletal muscle fatigue tolerance.
    Bourgeois Yoshioka CK; Takenaka-Ninagawa N; Goto M; Miki M; Watanabe D; Yamamoto M; Aoyama T; Sakurai H
    Stem Cell Res Ther; 2024 Sep; 15(1):313. PubMed ID: 39300595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PiggyBac-mediated approach for muscle gene transfer or cell therapy.
    Ley D; Van Zwieten R; Puttini S; Iyer P; Cochard A; Mermod N
    Stem Cell Res; 2014 Nov; 13(3 Pt A):390-403. PubMed ID: 25310255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy.
    Meng J; Counsell JR; Reza M; Laval SH; Danos O; Thrasher A; Lochmüller H; Muntoni F; Morgan JE
    Sci Rep; 2016 Jan; 6():19750. PubMed ID: 26813695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.
    Loperfido M; Jarmin S; Dastidar S; Di Matteo M; Perini I; Moore M; Nair N; Samara-Kuko E; Athanasopoulos T; Tedesco FS; Dickson G; Sampaolesi M; VandenDriessche T; Chuah MK
    Nucleic Acids Res; 2016 Jan; 44(2):744-60. PubMed ID: 26682797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation.
    Cui CH; Uyama T; Miyado K; Terai M; Kyo S; Kiyono T; Umezawa A
    Mol Biol Cell; 2007 May; 18(5):1586-94. PubMed ID: 17314403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice.
    Guibinga GH; Ebihara S; Nalbantoglu J; Holland P; Karpati G; Petrof BJ
    Mol Ther; 2001 Nov; 4(5):499-507. PubMed ID: 11708887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice.
    Nance ME; Shi R; Hakim CH; Wasala NB; Yue Y; Pan X; Zhang T; Robinson CA; Duan SX; Yao G; Yang NN; Chen SJ; Wagner KR; Gersbach CA; Duan D
    Mol Ther; 2019 Sep; 27(9):1568-1585. PubMed ID: 31327755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy.
    Pickar-Oliver A; Gough V; Bohning JD; Liu S; Robinson-Hamm JN; Daniels H; Majoros WH; Devlin G; Asokan A; Gersbach CA
    Mol Ther; 2021 Nov; 29(11):3243-3257. PubMed ID: 34509668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
    Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
    Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.
    Benedetti S; Uno N; Hoshiya H; Ragazzi M; Ferrari G; Kazuki Y; Moyle LA; Tonlorenzi R; Lombardo A; Chaouch S; Mouly V; Moore M; Popplewell L; Kazuki K; Katoh M; Naldini L; Dickson G; Messina G; Oshimura M; Cossu G; Tedesco FS
    EMBO Mol Med; 2018 Feb; 10(2):254-275. PubMed ID: 29242210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.
    Matre PR; Mu X; Wu J; Danila D; Hall MA; Kolonin MG; Darabi R; Huard J
    Stem Cells; 2019 Dec; 37(12):1615-1628. PubMed ID: 31574188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.